Gault Cheryl — SEC insider filings

SEC reporting owner CIK 1839046. 12 insider filings on record with FilingPulse; latest filed 2026-10-01.

Transaction summary — filings shown

Covers all 12 filings on record, filed 2021-12-10 to 2026-10-01. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Rapport Therapeutics, Inc. (RAPP)Chief Operating Officer10—11 legs · 42,014 sh · $1,429,9138
Cyclerion Therapeutics, Inc. (CYCN)Chief Operating Officer2——2

Insider filings — Gault Cheryl

FiledFormIssuerReported transactionsSource
2026-10-014Rapport Therapeutics, Inc. (RAPP)Sale (S): 7,925 @ $33.04 · Sale (S): 2,075 @ $33.76EDGAR
2026-07-014Rapport Therapeutics, Inc. (RAPP)Sale (S): 1,900 @ $40.09 · Sale (S): 3,792 @ $41.39 · Sale (S): 3,308 @ $42.17 · Sale (S): 1,000 @ $43.15EDGAR
2026-03-314Rapport Therapeutics, Inc. (RAPP)Sale (S): 7,161 @ $28.04 · Sale (S): 2,839 @ $28.55EDGAR
2026-03-094Rapport Therapeutics, Inc. (RAPP)Sale (S): 2,014 @ $28.93EDGAR
2026-02-044Rapport Therapeutics, Inc. (RAPP)Grant/award (A): 132,000 (derivative) @ $0EDGAR
2025-12-014Rapport Therapeutics, Inc. (RAPP)Option exercise (M): 5,000 @ $1.80 · Sale (S): 5,000 @ $30.10 · Option exercise (M): 5,000 (derivative) @ $0EDGAR
2025-09-104Rapport Therapeutics, Inc. (RAPP)Option exercise (M): 5,000 @ $1.80 · Sale (S): 5,000 @ $38.33 · Option exercise (M): 5,000 (derivative) @ $0EDGAR
2025-03-054Rapport Therapeutics, Inc. (RAPP)Grant/award (A): 13,987 @ $0EDGAR
2025-02-044Rapport Therapeutics, Inc. (RAPP)Grant/award (A): 129,000 (derivative) @ $0EDGAR
2024-06-104Rapport Therapeutics, Inc. (RAPP)Grant/award (A): 88,442 (derivative) @ $0EDGAR
2022-01-244Cyclerion Therapeutics, Inc. (CYCN)Grant/award (A): 135,000 (derivative) @ $0EDGAR
2021-12-104Cyclerion Therapeutics, Inc. (CYCN)Grant/award (A): 100,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2021-12-08 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1839046 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs